Abbott Laboratories buy Daiwa Capital Markets
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
€95.29
Performance (%)
-7.50%
Price
14:36
€85.38
Summary
This prediction is currently active. With a performance of -7.50%, the BUY prediction by Daiwa_Capital_Market is trending in the wrong direction. This prediction currently runs until 31.01.27. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Daiwa Capital Markets from $136.00 to $113.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Daiwa_Capital_Market for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.72
21.10.25
21.10.25
€116.80
21.10.26
21.10.26
-22.76%
14:36
14:36
